Table 3 Summary of studies published on rotational mechanical dilator sheaths for lead extraction
From: Rotational mechanical dilator sheaths for effective transvenous lead extraction
Author, reference | Extraction tools | Numbers | Lead age, patient age | Indications for TLE (n*) | Success rates | Complications | Comments |
|---|---|---|---|---|---|---|---|
Hussein (2010) [9] | Evolution | 41 leads in 29 patients | 111 ± 100 months, 64 ± 19 years | Infection (20), non-infection (9) | 86% (33 leads in 25 patients) | No major complication | Snare for 2 patients, laser for 2 patients |
Oto (2011) [14] | Evolution | 41 leads in 23 patients | 74 (25–180) months, 59 ± 14 years | Infection (7), non-infection (16) | 82% (35 leads in 19 patients) | No major complication | Snare required for 6 leads |
Witte (2017) [12] | Evolution RL versus Evolution | 149 leads in 103 patients | 6.8 versus 9.1Â years, 65 versus 68Â years | Infection (55), non-infection (48) | 98 versus 80% | No major complication | Bidirectional Evolution superior to unidirectional device |
Sharma (2018) [13] | Evolution RL, Evolution | 683 leads in 400 patients | 6.8 ± 4.4 year, 71 ± 13 years | Infection (29), non-infection (71) | 97% | 1.5% | Comparable performance of old and new Evolution |
Mazzone, (2018) [17] | Evolution RL | 238 leads in 124 patients | 92 ± 53 months, 65 ± 14 years | Infection (63), non-infection (61) | 98.7% (235 leads) | No major complication | Prospective Italian Registry, No lead wrapping |
Aytemir (2016) [11] | TightRail | 42 leads in 23 patients | 72 (18–216) months, 59 ± 14 years | Infection (12), non-infection (11) | 95.7% (TightRail alone) | No major complication | Femoral snare for one patient |
Diaz (2019) [18] | TightRail, Evolution (RL), Laser | 50,545 extractions | Not reported | Not reported | 13 deaths in RMD sheaths versus 167 deaths with laser sheaths | 7.2 times higher risk of mortality in laser than rotating sheaths | Â |
Bahadır (2021) [16] | TightRail versus Evolution (RL) | 556 leads in 302 patients | 5.0 (0.6–33) years, 60 (18–90) years | Infection (130), non-infection (172) | 94 versus 94% | 1.2 versus 3.8% | Similar efficacy and safety in both tools |
Choi (2022) [19] | TightRail | 131 leads in 86 patients | 11.7 ± 7.3 years, 66.3 ± 14.1 years | Infection (15), non-infection (71) | 93% | 8.1% | Lead age > 10 years was associated with major complication |